Inactive Instrument

Medidata Solutions, Inc. Stock price

Equities

US58471A1051

IT Services & Consulting

Dynamic Chart
Medidata Announces New Experiences for Enhancing and Streamlining Clinical Data Workflows: Clinical Data Studio and Health Record Connect CI
Medidata and EDETEK Announce Partnership to Revolutionize Global Clinical Trial Data Management CI
Medidata Solutions, Inc. announced that it has received funding from TFS HealthScience CI
Medidata Next New York to Unveil New Vision for Life Sciences Innovation CI
Medidata Announces Expansion of Multi-Year Partnership with Catalyst Clinical Research for Oncology Trials CI
Lambda Therapeutics Partners with Medidata to Automate and Streamline Data Management Processes for Greater Clinical Trial Efficiency CI
Allucent Expands Use of Medidata Clinical Cloud to Accelerate New Drug Development for Unmet Patient Needs CI
Medidata Launches New myMedidata Native App to Expedite Study Start Up and Improve Patient Experience CI
Aural Analytics, Inc. Partners with Medidata and Its Sensor Cloud Network CI
Medidata Launches New Clinical Operations Technologies to Address Critical Issues in Clinical Trial Oversight CI
MMS Holdings Announces Partnership with Medidata to Provide Medidata’s Advanced Rave EDC and Decentralized Clinical Trial Solutions to Sponsors CI
Ergomed Rare Disease Innovation Center to Leverage Medidata Patient Cloud, Intelligent Trials Technologies, and Synthetic Control Arm to Advance New Treatments CI
Plus Therapeutics, Inc. Expands Partnership with and Medidata CI
Labcorp Renews Strategic Partnership with Medidata to Provide Suite of Clinical Trial Technologies and Services CI
Circuit Clinical Solutions Inc. announced that it has received $29 million in funding from a group of investors CI
More news
Managers TitleAgeSince
Chief Executive Officer 54 18-12-31
Director of Finance/CFO - -
Chief Operating Officer 58 16-09-30
Members of the board TitleAgeSince
Chief Executive Officer 54 18-12-31
More insiders
Medidata Solutions Inc. (Medidata) is a provider of cloud-based solutions for life sciences. The Company provides cloud-based solutions for clinical research in life sciences, offering platform technology that focuses on the clinical development. The Company's plan study addresses three areas to ensure optimal study design, grant development and negotiation, and investigator payments. Study Design Optimization enables customers to gain visibility into the impact of protocol elements on resource and trial endpoints. Grants Manager compares specific industry benchmarks and analytics, using industry's database of negotiated procedure costs, to support appropriate grants to investigator sites and automated negotiations with multiple investigator sites. Payments enables customers to establish a global investigator payment strategy and process to automate payment calculation, distribution and reporting, including tax and currency exchange calculations.
More about the company
  1. Stock
  2. Equities
  3. Stock Medidata Solutions, Inc. - Nasdaq